Sun Pharma’s profit falls on Organon deal charge; specialty drug sales remain strong
Specialty sales rose 6.9% to $356 million as a 12.69 billion rupee charge tied to Organon cut quarterly profit, the company said.
5 Articles
5 Articles
India’s Sun Pharma posts lower quarterly profit on one-time acquisition-related charge - Regional Media News
Oct 30 (Reuters) - India's Sun Pharmaceutical Industries reported a drop in second-quarter profit on Friday, dragged by a one-time charge related to its acquisition of Organon. Consolidated net profit fell to 19.89 billion rupees ($209.31 million) in the quarter ended September 30 from 31.18 [...]
Sun Pharma’s profit falls on Organon deal charge; specialty drug sales remain strong
Oct 30 (Reuters) - India's Sun Pharmaceutical Industries reported a drop in second-quarter profit on Friday, as a one-time charge largely tied to its planned acquisition of Organon weighed, though demand for specialty medicines remained strong. The c...
Sun Pharma Q2 Results: Profit falls 36% YoY to Rs 1,989 crore on exceptional charges
Sun Pharma Q2 Results: Revenue from operations rose 12% YoY to Rs 16,199 crore from Rs 14,478 crore in Q2 of last financial year, supported by strong growth in its domestic formulations business and emerging markets.
Sun Pharma Q2 Results: Net Profit Falls 36% to Rs 19,885 Crore on Exceptional Charges; Revenue Rises 12%
Noida, Oct 30 (APAC Media): Sun Pharma on Friday reported a 36.23 per cent year-on-year decline in consolidated net profit at Rs 19,885 crore for the July-September quarter of FY26, compared with Rs 31,180 crore in the corresponding quarter of the previous financial year, the company said in a regulatory filing. The company’s revenue from […] The post Sun Pharma Q2 Results: Net Profit Falls 36% to Rs 19,885 Crore on Exceptional Charges; Revenue …
Coverage Details
Bias Distribution
- 75% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
